Overview
- 17 inspections across 13 sites are on record.
- 43 Form 483 observations are attributed to this investigator.
- Most recent recorded activity is 2026-05-22.
At a glance
Inspections
17
Sites
13
Observations
43
Career since
Mar 2024
Recent inspections
Most recent inspections in the published record.
| Site | Date | Category | Form 483 |
|---|---|---|---|
| I 3 PHARMACEUTICALS, LLC | 22 May 2026 | Human Drugs | View 483 → |
| Accugenix LLC | 22 Apr 2026 | Human Drugs | |
| Newton Laboratories, Inc. | 26 Mar 2026 | Human Drugs | View 483 → |
| KP Pharmaceutical Technology | 13 Feb 2026 | Human Drugs | |
| J.M. Murray Center, Inc. | 19 Sep 2025 | Human Drugs | View 483 → |
Sites inspected
I 3 PHARMACEUTICALS, LLCWarminster, United States1 insp.
Accugenix LLCNewark, United States1 insp.
Newton Laboratories, Inc.Conyers, United States1 insp.
KP Pharmaceutical TechnologyBloomington, United States1 insp.
J.M. Murray Center, Inc.Cortland, United States1 insp.
Co-investigators
Investigators who share inspections with this person.
Stephenie M Ortiz5 shared
JoshRenzo N Ramilo4 shared
Josh Renzo N Ramilo4 shared
Edmund F Mrak2 shared
Michelle Lin1 shared
Emily A Walters1 shared
Lisa R Hilliard1 shared
Martin M Kimani1 shared
Robert J Ham1 shared
Catherine O Lamptey1 shared
Full investigator report
Get the verbatim findings behind John D Mcintosh's 43 observations
Source 483 PDFs, verbatim observations, and how each site responded, so your team knows what they cite before they arrive.
- New inspections and Form 483s, mapped to the CFR citation
- Warning letter outcomes, and the citation patterns they repeat
- Their co-investigators, so no surprises about who shows up on site